UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 10, 2020

Nuvectra Corporation

(Exact Name of Registrant as Specified in its Charter)

5830 Granite Parkway, Suite 1100,

Plano, Texas 75024

(Address of principal executive offices, including zip code)

(214) 474-3107

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Item 8.01     Other Events.

Confirmation Hearing

As previously disclosed, on November 12, 2019, Nuvectra Corporation (the “Company”) filed a voluntary petition for reorganization under Chapter 11 of the U.S. Bankruptcy Code (the “Chapter 11 Case”) in the U.S. Bankruptcy Court for the Eastern District of Texas (the “Bankruptcy Court”). The Chapter 11 Case is being administered under the caption In re Nuvectra Corporation, Case No. 19-43090.

On March 10, 2020, the Company filed a notice with the Bankruptcy Court (the “Notice”) scheduling a confirmation hearing with respect to the Plan of Liquidation of Nuvectra Corporation Under Chapter 11 of the Bankruptcy Code (the “Plan”). The hearing to confirm the Plan will commence on April 17, 2020 at 2:00 p.m. CT and will take place at the Bankruptcy Court, which is located at 660 North Central Expressway, Suite 300B, Plano, TX 75074. The deadline for filing and serving objections to confirmation of the Plan is April 8, 2020 at 5:00 p.m. CT. The deadline by which ballots accepting or rejecting the Plan must be submitted is April 13, 2020 at 5:00 p.m. CT.

The above summary does not purport to be complete and is qualified in its entirety to the text of the Notice, a copy of which is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein. This Current Report on Form 8-K is not a solicitation to accept or reject the Plan. Any such solicitation will be made pursuant to and in accordance with the Disclosure Statement describing the Plan (the “Disclosure Statement”) and applicable law, including orders of the Bankruptcy Court.

Additional Information Regarding the Chapter 11 Case

Filings with the Bankruptcy Court related to the Chapter 11 Case are available on the case website maintained by Kurtzman Carson Consultants LLC (“KCC”), available at http://www.kccllc.net/nuvectra. In addition to accessing the case website, any person who desires to obtain a copy of the Plan or the Disclosure Statement may request such copies by: (a) accessing the Bankruptcy Court’s website at http://www.txeb.uscourts.gov; (b) contacting the Office of the Clerk of the Court, United States Bankruptcy Court Eastern District of Texas, 660 North Central Expressway, Suite 300B, Plano, TX 75074; or (c) contacting KCC at 1-888-201-2205 (US and Canada) or 1-310-751-1839 (outside the US and Canada), or via e-mail at NuvectraInfo@kccllc.com. Information contained on, or that can be accessed through, the case website, the Bankruptcy Court or KCC is not part of this Current Report on Form 8-K, and the Company disclaims liability for any such information.

Forward-Looking Statements

This Current Report on Form 8-K contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based only on the Company’s current beliefs, expectations and assumptions regarding the future of the Company’s business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions, and therefore they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and may be outside of the Company’s control. The Company’s performance may differ materially from those indicated in the forward-looking statements, and you should not rely on any of these forward-looking statements. Any forward-looking statement made by the Company is based only on information currently available to the Company and speaks only as of the date on which it is made. Important factors that could cause the Company’s actual results to differ materially from those indicated in the forward-looking statements include: (i) the Company’s ability to obtain Bankruptcy Court approval with respect to motions in the Chapter 11 Case; (ii) whether the Chapter 11 Case will enable to Company to sell its assets in an orderly manner; (iii) the Company’s ability to realize proceeds from any sale of assets; (iv) the effects of the Chapter 11 Case on the Company and the interests of the Company’s creditors, equityholders and other stakeholders; (v) the length of time the Company will operate under the Chapter 11 Case; (vi) risks associated with third party motions in the Chapter 11 Case; (vii) risks that the Chapter 11 Case could be converted into a case under Chapter 7 of the Bankruptcy Code; (viii) potential adverse effects of the Chapter 11 Case proceedings on the Company’s cash position and continuing operations; (ix) risks related to the Company’s ability to confirm the Plan; (x) the impact of the coronavirus disease 2019 (COVID-19); and (xi) other risk factors set forth in the Disclosure Statement. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Item 9.01     Financial Statements and Exhibits.

(d)     Exhibits

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.